TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer

Clinical trial NCT00102973 · COMPLETED

Trial details

NCT number: NCT00102973
Sponsor: Telik
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ovarian Neoplasms

Start date: 2004-12-01
Primary completion: 2008-07-01
Enrollment: 244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.